Cargando…
The Evolving Landscape of Immunotherapy in Locally Advanced Rectal Cancer Patients
SIMPLE SUMMARY: At the last 2022 annual ASCO meeting, impressive results of anti-PD1 activity in clinical stage 2 and 3 microsatellite instable rectal cancer patients have been published. Moreover, a growing number of studies assessed the synergism between neoadjuvant (chemo)radiotherapy and immunot...
Autores principales: | Germani, Marco Maria, Carullo, Martina, Boccaccino, Alessandra, Conca, Veronica, Masi, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496787/ https://www.ncbi.nlm.nih.gov/pubmed/36139613 http://dx.doi.org/10.3390/cancers14184453 |
Ejemplares similares
-
Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability
por: Borelli, Beatrice, et al.
Publicado: (2022) -
Circulating tumour DNA in the evolving treatment landscape of locally advanced rectal cancer: where does it fit in?
por: Piercey, Oliver, et al.
Publicado: (2023) -
Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution
por: Cesario, Silvia, et al.
Publicado: (2023) -
Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease
por: Dietrich, Brian, et al.
Publicado: (2018) -
Implementing revised RED approaches to immunize in an evolving African landscape
por: Burgess, Craig Alexander
Publicado: (2017)